Business
GE HealthCare announces lead industrial role in largest EU-funded IHI consortium to advance cardio-oncology care across Europe
CHICAGO, March 26, 2026--GE HealthCare (Nasdaq: GEHC) today announced its leading industrial role in the new COMPASS consortium, a five-year initiative focused on improving precision cardio-oncology care and advancing early detection of cardiovascular risks in cancer patients across Europe. COMPASS combines clinical excellence with novel healthcare technology, and with a total budget of €50.5 million and more than sixty partners, it is one of the largest public-private partnerships under the IHI
About this update from Compass, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":6570,"height":2242,"url":"https://media.zenfs.com/en/business-wire.com/ecf2694c8afe461f9d6c39b4a66e876c"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/_7W8ehY98aqx9zmQzhuzEw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTMyOA--/https://media.zenfs.com/en/business-wire.com/ecf2694c8afe461f9d6c39b4a66e876c","width":960,"height":328},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/G2_MI3yW6VIGNxWlxH4mSw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD04MTg-/https://media.zenfs.com/en/business-wire.com/ecf2694c8afe461f9d6c39b4a66e876c","width":1200,"height":409}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"COMPASS is one of the largest public‑private partnerships under the European Union’s (EU) Innovative Health Initiative (IHI).","length":125,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"The consortium aims to advance early detection and prediction of cardiotoxicity in cancer patients and cancer survivors.","length":120,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"The initiative will leverage AI, advanced imaging, biomarkers, and integrated care pathways.","length":92,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":337,"olType":false},{"type":"text","content":"CHICAGO, March 26, 2026--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced its leading industrial role in the new COMPASS consortium, a five-year initiative focused on improving precision cardio-oncology care and advancing early detection of cardiovascular risks in cancer patients across Europe. COMPASS combines clinical excellence with novel healthcare technology, and with a total budget of €50.5 million and more than sixty partners, it is one of the largest public-private partnerships under the IHI.","length":518,"tagName":"p"},{"type":"text","content":"Cardiovascular diseases are rising sharply among cancer patients and survivors, driven both by the increasing prevalence of pre‑existing cardiovascular conditions at diagnosis and by the expanding use of highly effective antitumor therapies - including chemotherapy, radiotherapy and targeted therapies - many of which are associated with cardiovascular toxicities. Global studiesi show that heart-related com...